Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cells

Journal of Investigative Dermatology

Volumn 105, Issue 2, 1995, Pages 248-253

  Piantelli, M ^a   Maggiano, N ^a   Ricci, R ^a   Larocca, L M ^a   Capelli, A ^a   Scambia, G ^a   Isola, G ^a   Natali, P G ^a   Ranelletti, F O ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Antiestrogens; Antitumor agent; Estrogen receptor; Flavonoids

Indexed keywords

ANDROSTANOLONE; ANTIESTROGEN; DEXAMETHASONE; DIETHYLSTILBESTROL; ESTROGEN RECEPTOR; FULVESTRANT; PROGESTERONE; QUERCETIN; RUTOSIDE; TAMOXIFEN;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0029096256     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12317599     Document Type: Article

References (47)

1. Syne J.S. Markaverich B.M. Clark J.H. Panko W.B. Estrogen binding sites in the nucleus of normal and malignant tissue: characteristics of the multiple binding sites Cancer Res 42 1982 4449 4454
2. Markaverich B.M. Clark J.H. Two binding sites for estradiol in rat uterine nuclei: relationship to uterotrophic response Endocrinology 105 1979 1458 1462
3. Markaverich B.M. Roberts R.R. Alejandro M.A. Johnnan G.A. Middleditch B.S. Clark J.H. Bioflavonoid interaction with rat uterine type II binding sites and growth inhibition J Steroid Biochem 30 1988 71 78
4. Markaverich B.M. Gregory R.R. Alejandro M.A. Kittrel F.S. Medina D. Clark J.H. Varma M. Verma R.S. Methylp-hydroxy-phenylllactate and nuclear type II binding sites in malignant cells; metabolic fate and mammary tumor growth Cancer Res 50 1990 1470 1478
5. Gabor M. Szent-Gyorgyi and the bioflavonoids: new results and perspectives of pharmacological research into benzo-pyrone derivatives V. Cody E. Middleton Jr J.B. Harborne A. Beretz Plant Flavonoids in Biology and Medicine. II: Biochemical, Cellular, and Medical Properties. Progress in Clinical and Biological Research 280 1988 Alan R. Liss New York 1 15
6. Scambia G. Ranelletti F.O. Benedetti Panici P. Piantelli M. Bonanno G. De Vincenzo R. Ferrandina G. Rumi C. Larocca L.M. Mancuso S. Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumors and cultured cells Br J Cancer 62 1990 942 946
7. Piantelli M. Ricci R. Larocca L.M. Rinelli A. Capelli A. Rizzo S. Scambia G. Ranelletti F.O. Type II oestrogen binding sites in human colorectal carcinoma J Clin Pathol 43 1990 1004 1006
8. Piantelli M. Rinelli A. Macri E. Maggiano N. Larocca L.M. Scerrati M. Roselli R. Iacoangeli M. Scambia G. Capelli A. Ranelletti F.O. Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomas Cancer 71 1993 193 198
9. Larocca L.M. Teofili L. Leone G. Sica S. Menichella G. Scambia G. Benedetti Panici P. Ricci R. Piantelli M. Ranelletti F.O. Antiproliferative activity of quercetin on normal bone marrow and leukaemic progenitors Br J Haematol 79 1991 562 566
10. Scambia G. Ranelletti F.O. Benedetti Panici P. Piantelli M. Bonanno G. De Vincenzo R. Ferrandina G. Capelli A. Mancuso S. Quercetin inhibits the growth of a multidrug-resistant, estrogen-roceptor-negative MCF-7 human breast cancer cell line expressing type II estrogen binding sites Cancer Chemother pharmacol 28 1991 255 258
11. Scambia G. Ranelletti F.O. Benedetti Panici P. Piantelli M. Rumi C. Battaglia F. Larocca L.M. Capelli A. Mancuso S. Type II estrogen binding sites in a lymphoblastoid cell line and growth-inhibitory effect of estrogen, anti-estrogen and bioflavonoids Int J Cancer 46 1991 1112 1116
12. Del Prete S.A. Maurer L.H. O'Donnel J. Forcier R.J. Le Marbre P. Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma Cancer Treat Rep 68 1984 1403 1405
13. Buzaid A.C. Murren J.R. Durivage H.J. High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma Cancer 68 1991 1238 1241
14. Cocconi G. Bella M. Calabresi F. Tonato M. Canaletti R. Boni C. Buzzi F. Ceci G. Corgna E. Costa P. Lottici R. Papadia F. Sofra M.C. Bacchi M. Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen N Engl J Med 327 1992 516 523
15. McClay E.F. Mastrangelo M.J. Berd D. Bellet R.E. Effective combination chemo/hormonal therapy for malignant melanoma: experience with three consecutive trials Int J Cancer 50 1992 553 556
16. Fierro M.T. Bertero M. Novelli M. Appino A. Doveil G.C. Colonna S. Bernengo M.G. Therapy for metastatic melanoma; effective combination of dacarbazine, carmustine, cisplatin and tamoxifen Melanoma Res 3 1993 127 131
17. Reintgen D. Saba H. Chemotherapy for stage 4 melanoma: a three-year experience with cisplatin, DTIC, BCNU, and tamoxifen Semin Surg Oncol 9 1993 251 255
18. McClay E.F. Albright K.D. Jones J.A. Christian R.D. Howell S.B. Tamoxifen modulation of cisplatin sensitivity in human malignant melanoma cells Cancer Res 53 1993 1571 1576
19. Wilson B.S. Imai K. Natali P.G. Ferrone S. Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies Int J Cancer 28 1981 293 300
20. Cuomo M. Nicotra M.R. Apollonj C. Fraioli R. Giacomini P. Natali P.G. Production and characterization of the murine monoclonal antibody 2G10 to a human T4-tyrosinase epitope J Invest Dermatol 96 1991 446 451
21. Hamburger A.W. Salmon S.E. Primary bioassay of human stem cell Science 197 1977 461 463
22. Ranelletti F.O. Ricci R. Larocca L.M. Maggiano N. Capelli A. Scambia G. Mancuso S. Rumi C. Piantelli M. Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary tumors Int J Cancer 50 1992 486 492
23. Burton K. A study of the condition and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid Biochem J 62 1956 315 318
24. Scatchard G. The attraction of proteins for small molecules and ions Ann NY Acad Sci 51 1949 660 672
25. Berthois Y. Katzellenbogen J.A. Katzellenbogen B.S. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen responsive cells in culture Proc Natl Acad Sci USA 83 1986 2496 2500
26. Chander S.K. Sahota S.S. Evans T.R.J. Luqmani Y.A. The biological evaluation of novel antiestrogens for the treatment of breast cancer Crit Rev Oncol Hematol 15 1993 243 269
27. Feucht K.A. Walker M.J. Das Gupta T.K. Beattie G.W. Effect of 17β-estradiol on the growth of estrogen receptor-positive human melanoma in vitro and in athymic mice Cancer Res 48 1988 7093 7101
28. Schleicher R.L. Hitselberger M.H. Beattie C.W. Inhibition of hamster melanoma growth by estrogens Cancer Res 47 1987 453 459
29. Walker M.J. Chaudhuri P.K. Beattie C.W. Tito W.A. Gupta T.K. Neuroendocrine and endocrine correlates to hamster melanoma growth in vitro Surg Forum 29 1978 151 152
30. Gill P.G. De Young N.J. Thompson A. Keightley D.D. Horsfall D.J. The effect of tamoxifen on the growth of human malignant melanoma in vitro Eur J Clin Oncol 20 1984 807 815
31. O'Brian C.A. Ward N.E. Anderson B.W. Role of specific interactions between protein kinase C and triphenylethylenes in inhibition of the enzyme J Natl Cancer gust 80 1988 1628 1633
32. Darbre P.D. Curtis S. King R.J.B. Effects of estradiol and tamoxifen on human cancer cells in serum-free culture Cancer Res 44 1984 2790 2793
33. Su H.D. Mazzei G.J. Vogler W.R. Kua J.F. Effects of tamoxifen, a non steroidal antiestrogen, on phospholipid/calcium-dependent protein kinase and phosphorylation of its endogenous substrate proteins from rat brain and ovary Biochem Pharmacol 34 1985 3649 3653
34. Baltuch G.H. Couldwell W.T. Villemure J.-G. Yong V.W. Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen Neurosurgery 33 1993 495 501
35. Grunicke H. Hofmann J. Maly K. Uberall F. Posch L. Oberhuber H. Fiebig H. The phospholipid and calcium dependent protein kinase as a target in tumor chemotherapy Adv Enzyme Regul 28 1989 201 210
36. Couldwell W.T. Hinten D.R. He S. Chen T.C. Sebat I. Weiss M.H. Lawr E. Protein kinase inhibitors induce apoptosis in human malignant glioma cell line FEBS Lett 345 1994 43 46
37. Wei Y.Q. Zhao X. Kariya Y. Fukat H. Teshigawara K. Uchida A. Induction of apoptosis by quercetin: involvement of heat-shock protein Cancer Res 54 1994 4952 4957
38. McClay E.F. Albright K.D. Jones J.A. Christen R.D. Howell S.B. Tamoxifen delays the development of resistance to cisplatin in human melanoma and ovarian cancer cell lines Br J Cancer 70 1994 449 452
39. Scambia G. Ranelletti F.O. Benedetti P. Piantelli M. De Vincenzo R. Bonanno G. Ferrandina G. Isola G. Mancuso S. Synergistic antiproliferative activity of tamoxifen and cisplatin on primary ovarian tumours Eur J Cancer 28 1992 1885 1889
40. Hofmann J. Fiebig H.H. Winterhalter B.R. Berger D.P. Grunicke H. Enhancement of the antiproliferative activity of cis-diaminedichloro-platinum by quercetin Int J Cancer 45 1990 536 539
41. Lien E.A. Solheim E. Ueland P.M. Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment Cancer Res 51 1991 4837 4842
42. Gugler R. Leschik M. Dengler M.J. Disposition of quercetin in man after single oral and intravenous doses Eur J Clin Pharmacol 9 1975 229 235
43. Knabbe C. Lippman M.E. Wakefield L.M. Flanders K.C. Kasid A. Derynck R. Dickson R.B. Evidence that TGF-β is a hormonally regulated negative growth factor in human breast cancer cells Cell 48 1987 417 428
44. Scambia G. Benedetti Panici P. Ranelletti F.O. Ferrandina G. De Vincenzo R. Piantelli M. Masciullo V. Bonanno G. Isola G. Mancuso S. Quercetin enhances transforming growth factor β1 secretion by human ovarian cancer cells Int J Cancer 57 1994 211 215
45. Wieland I. Muller G. Braun S. Birchmeier W. Reversion of the transformed phenotype of Bl6 mouse melanoma: involvement of an 83 Kd cell surface glycoprotein in specific growth inhibition Cell 47 1986 675 685
46. Albino A.P. Davis B.M. Nanus D.M. Induction of growth factor RNA expression in human malignant melanoma: markers of transformation Cancer Res 51 1991 4815 4820
47. Rodeck U. Bossler A. Graever U. Fox F.E. Nowell P.C. Knabbe C. Kari C. Transforming growth factor β production and responsiveness in normal human melanocytes and melanoma cells Cancer Res 54 1994 575 581